




Pain and sensitization after total knee replacement or nonsurgical treatment in patients
with knee osteoarthritis
Identifying potential predictors of outcome at 12 months
Arendt-Nielsen, Lars; Simonsen, Ole; Laursen, Mogens Berg; Roos, E. M.; Rathleff, Michael
Skovdal; Rasmussen, Sten; Skou, Søren Thorgaard
Published in:
European Journal of Pain





Accepted author manuscript, peer reviewed version
Link to publication from Aalborg University
Citation for published version (APA):
Arendt-Nielsen, L., Simonsen, O., Laursen, M. B., Roos, E. M., Rathleff, M. S., Rasmussen, S., & Skou, S. T.
(2018). Pain and sensitization after total knee replacement or nonsurgical treatment in patients with knee
osteoarthritis: Identifying potential predictors of outcome at 12 months. European Journal of Pain, 22(6), 1088-
1102. https://doi.org/10.1002/ejp.1193
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
            ? Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
            ? You may not further distribute the material or use it for any profit-making activity or commercial gain
            ? You may freely distribute the URL identifying the publication in the public portal ?
Take down policy
If you believe that this document breaches copyright please contact us at vbn@aub.aau.dk providing details, and we will remove access to










This article has been accepted for publication and undergone full peer review but has not 
been through the copyediting, typesetting, pagination and proofreading process, which may 
lead to differences between this version and the Version of Record. Please cite this article as 
doi: 10.1002/ejp.1193 
This article is protected by copyright. All rights reserved. 
 Article Type: Original Article 
 
Pain and Sensitisation after Total Knee Replacement or Non-Surgical 
Treatment in Patients with Knee Osteoarthritis: Identifying Potential 
Predictors of Outcome at 12 Months 
 
L. Arendt-Nielsen, PhD, DMSc a; O. Simonsen, MD, DMSc a,b,c; M. B. Laursen, MD, PhD a,b,c; E. M. Roos, 
PT, PhD d; M. S. Rathleff, PT, PhD a; S. Rasmussen MD, PhD a,b,c; S. T. Skou, PT, PhDa,b,d,e 
a SMI, Department of Health Science and Technology, Faculty of Medicine, Aalborg University, 9220 
Aalborg, Denmark  
b Orthopedic Surgery Research Unit, Aalborg University Hospital, 9000 Aalborg, Denmark  
c Department of Clinical Medicine, Aalborg University, 9000 Aalborg, Denmark 
d Research Unit for Musculoskeletal Function and Physiotherapy, Department of Sports Science and 
Clinical Biomechanics, University of Southern Denmark, 5230 Odense, Denmark  
e Department of Physiotherapy and Occupational Therapy, Næstved-Slagelse-Ringsted Hospitals, 
Region Zealand, 4200 Slagelse, Denmark  
 
Running head: 
Predicting outcome after TKR and non-surgical treatment  
 
Corresponding author:  
Prof., dr.med. Lars Arendt-Nielsen, SMI, Department of Health Science and Technology, Faculty of 







The RCTs were partially funded by grants from: The Danish Rheumatism Association (OS, STS), The 
Health Science Foundation of North Denmark Region (STS), Obel Family Foundation (SR), Foot 










This article is protected by copyright. All rights reserved. 
of Danish Physiotherapists Research Fund (STS), Medical Specialist Heinrich Kopps Grant (STS), and 
The Danish Medical Association Research Fund (STS). 
 




Human experimental pain assessment was used to assess the degree of pain sensitisation in 
patients with painful knee osteoarthritis. High sensitisation before total knee replacement 
predicted worse outcome. Outcome after non-surgical interventions could not be predicted. 
 
Abstract  
Background: This study is a secondary analysis of 12-month follow-ups from two parallel, 
randomised controlled trials (RCT) in painful knee osteoarthritis patients. RCT1: Total knee 
replacement (TKR) followed by non-surgical treatment compared with non-surgical 
treatment. RCT2: Non-surgical treatment compared with usual care. 
The aims were to investigate 1) possible predictors of treatment outcome after TKR and non-surgical 
interventions at 12 months, 2) associations between pain intensity and pressure pain thresholds 
(PPTs) (pain sensitisation) at baseline and after 12 months, and 3) possible gender differences. 
Method: Each RCT included 100 patients. Pain intensities, PPTs, and number of painful sites were 
assessed at baseline and after 12 months. 
Results: In all groups pain improved and pain sensitisation decreased. In RCT1, the TKR group had 
the greatest improvements in pain. In RCT2 the non-surgical group had the greatest improvement, 
with no between-group differences in PPTs. Lower PPTs at baseline predicted higher pain after TKR. 
Baseline pain intensity and PPT levels were associated with the number of painful sites. Subjects 
with the highest pain and lowest PPTs at baseline showed the largest relative improvement in pain 
and sensitisation but were still experiencing highest absolute pain and lowest PPTs after 12 months 
(combined cohorts).   
Conclusion: Low PPTs at baseline predicted worse pain outcome after TKR, but did not predict 
outcome after non-surgical interventions. The number of painful sites was weakly associated with 
pain and PPTs, and the higher pain/lower PPTs, the higher pain/lower PPTs at 12 months with 
females showing the lowest PPT values. 
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Introduction  
Recent projections estimate a six- to seven-fold increase in total knee replacements (TKRs) by 2030  
(Kurtz et al., 2007) in patients with osteoarthritis (OA). While most patients experience pain relief 
after TKR, approx. 20% of the patients do not improve or are doing worse compared with before 
surgery (Beswick et al., 2012). However, this prevalence depends on the duration after TKR (e.g. 6 or 
12 months). 
This calls for a research focus on the selection of the right patients for TKR, i.e. those who will 
benefit the most, and on the criteria that may aid in selecting the optimal combination of non-
surgical treatments. Recently, mechanistic biomarkers have been used as pain assessment tools to 
evaluate patients at risk of developing continued post-operative pain after an otherwise successful 
joint replacement (Arendt-Nielsen, 2017). Few formal predictive tools are available to determine 
good or poor responders to TKR (Dowsey et al., 2014). Therefore, comprehensive sensory testing 
platforms are needed for more mechanistic profiling (Arendt-Nielsen et al., 2015a). 
A study by Wylde et al. (Wylde et al., 2015) showed an association of pressure pain thresholds (PPTs) 
(assessed from a site (arm) extrasegmentally to the affected knee) with higher pain severity 12 
months after hip replacement. However, despite the association between PPTs and pain severity, 
preoperative PPTs did not predict the efficacy of joint replacement in providing pain relief.  
Therefore, assessing PPT from further locations could provide a more complete pain profile 
(compared with other  studies using a sole measure of PPT at the arm as an indicator of widespread 
sensitization). So far no studies have investigated if the degree of pain sensitisation (assessed by 
PPTs from different sites) can predict the effect of non-surgical interventions compared with TKR in a 
cohort of similar patients.  
As an alternative to TKR due to the high prevalence of chronic postoperative pain, the role of non-
surgical procedures, e.g. comprehensive exercise programs, has attracted increased interest (Skou et 
al., 2015b). Exercise-induced analgesia has been specifically investigated in patients with OA, but 
without significantly positive effect on the pain sensitisation (Kosek et al., 2013). However, it may be 
one contributing factor to the modulation of clinical pain in general (Skou et al., 2016c). The 
fundamental aspects of exercise-induced analgesia have been studied intensively and some of the 
involved central pathways identified (Lima et al., 2017). In patients with OA, exercise has been 
shown to reduce pain sensitivity (increased PPTs) (Burrows et al., 2014). This has been associated 
with beneficial clinical effects in some studies (Henriksen et al., 2014), but not in others (Kosek et al., 
2013). Currently, no studies have identified predictors of outcome after exercise in OA patients. 
The aims of this study were to investigate: 1) possible predictors of treatment outcome after both 
TKR and non-surgical interventions at 12 months, 2) associations between pain intensity and PPTs 
(surrogate for pain sensitisation) at baseline and after 12 months and compare between the two 




This was an ancillary analysis of predictors of the 12-month results from two two-arm parallel group 
assessor-blinded randomised controlled trials (RCTs) conforming to the CONSORT statement for 
reporting RCTs (Moher et al., 2010) and the STROBE statement for reporting observational studies 
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defined in the statistical analysis plans, which were made available before any analyses commenced 
(Skou et al., 2014b; Skou et al., 2014c).  
All details of the recruitment process, full eligibility criteria, the process of randomisation, study 
flow, allocation concealment, and detailed description of the interventions were published in the 




Subjects were recruited via the Department of Orthopaedics in the Northern Denmark Region, 
Denmark, between September 2011 and December 2013. Data from the 200 patients with 
symptomatic knee OA considered eligible (N=100) (Skou et al., 2015b) or not eligible (N=100) (Skou 
et al., 2015a) for TKR were included in the analyses.  
The two RCTs (Skou et al., 2015a; Skou et al., 2015b) had the following shared inclusion criterion: 
aged≥18 years. Further, the following major, shared exclusion criteria applied: 1) mean pain the 
previous week >60 mm on a 100 mm visual analogue scale (VAS) and 2) previous knee replacement 
in the same side. When the studies were initiated, the surgeons found it unethical not to offer 
surgery to patients with pain above 60 mm on a 0-100 VAS. 
The first RCT (Skou et al., 2015b) had two additional inclusion criteria: 1) considered eligible for TKR 
by the orthopaedic surgeon (decision among other factors typically based on pain, function, and 
radiographic severity (Carr et al., 2012)) and 2) diagnosed with radiographic knee OA (Kellgren-
Lawrence (K&L) score≥2 on the original scale (Schiphof et al., 2011)). Further, the study had one 
major additional exclusion criterion: a need for bilateral simultaneous TKR.  
The second RCT (Skou et al., 2015a) had two additional inclusion criteria: 1) considered not eligible 
for TKR by the orthopaedic surgeon and 2) diagnosed with knee OA with a K&L score≥1 on the 
original scale (Schiphof et al., 2011). Further, RCT2 had one major additional exclusion criterion: 1) 
scores higher than 75 on a 0-100 worst to best scale in the self-report questionnaire Knee Injury and 
Osteoarthritis Outcome Score (KOOS4) defined as the average score for the subscale scores for pain, 
symptoms, activities of daily living (ADL), and quality of life (QOL) (Collins et al., 2016).  
The subjects of the two RCTs were of similar age and reported similar baseline pain levels (Skou et 
al., 2016a). The major differences were the radiographic OA severity, functional limitations, and 
whether they were eligible for TKR or not (Skou et al., 2016a). 
The local North Denmark Region Committee on Health Research Ethics (N-20110024 and N-
20110085) provided ethical approvals for both studies, the participants gave informed consent to 
participate, and the studies were conducted in accordance with the Helsinki Declaration. The studies 
were registered at ClinicalTrials.gov (NCT01410409 and NCT01535001). 
 
Interventions 
The first RCT randomised to TKR followed by non-surgical treatment or non-surgical treatment alone 
(Skou et al., 2015b) while the second RCT randomised to non-surgical treatment or usual care (Skou 
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Total Knee Replacement 
Subjects randomised to TKR followed by non-surgical treatment had a totally cemented prosthesis 
with patellar resurfacing (NexGen, CR-Flex, fixed bearing or LPS-Flex, fixed bearing, Zimmer, Warsaw, 
Indiana, USA) using standard surgical methods (Endres, 2011). 
 
Non-surgical Treatment 
The 3-month non-surgical treatment included education, exercise, and insoles while weight loss 
and/or pain medication were prescribed if indicated. Physiotherapists and dieticians gave the 
treatments at Aalborg University Hospital, Denmark. The selection of procedures and interventions 
were composed based on clinical experience and practice. Hence, it is not possible to judge the 
relative contributions from the individual procedures/interventions. 
 
Education 
The education comprised two 60-min sessions engaging the subjects and focusing on disease 
characteristics, OA pain, and how to control and monitor the pain during exercise, advice on 
treatment, and help to self-help.  
 
Exercise 
The NEuroMuscular EXercise training program (NEMEX), previously found feasible in patients with 
moderate to severe OA (Ageberg et al., 2010b), was delivered under supervision twice weekly with 
each session lasting 60 min. The program is based on neuromuscular and biomechanical principles 
and has different difficulty levels for each individual exercise (Ageberg et al., 2010b). The exercise 
program was followed by a transition period of eight weeks to gradually accustom the subjects to 
continue exercising after termination of the supervised program.  
 
Dietary Advice 
Subjects with a body mass index (BMI) ≥25 at baseline underwent a dietary weight loss program 
based on principles from motivational interviewing (Miller and Rollnik, 2002)  consisting of four 60-
min sessions aiming at reducing the body weight by at least 5% (Christensen et al., 2007).  
 
Insoles 
The subjects received individually fitted full-length Formthotics Original Dual Medium (perforated) 
insoles with medial arch support (Foot Science International, Christchurch, New Zealand). The 
subjects were tested with the valid and reliable Single Limb Mini Squat Test (Ageberg et al., 2010a). 
A 4° lateral wedge was added to the insoles of the subjects with a knee-lateral-to-foot position in the 
test (the knee moves over or lateral to the 5th toe in three or more of five trials).  
 
Pain Medication 
Paracetamol 1 g four times daily, ibuprofen 400 mg three times daily, and pantoprazole 20 mg daily 
were prescribed by the treating orthopaedic surgeon if indicated. The prescription was reassessed 
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Usual Care  
The subjects in the usual care group were given two standardised information leaflets: One with 
information on knee OA with regard to etiology, symptoms, common functional limitations, 
recommended treatments, and general advice on how to address the symptoms and a second leaflet 
with information as to where to seek advice in The North Denmark Region regarding treatment and 
how to achieve a healthy lifestyle.  
 
Outcomes 
Baseline and 12-month follow-up were carried out at the Department of Occupational Therapy and 
Physiotherapy, Aalborg University Hospital, Denmark. The assessor was not affiliated with the 
treatment sites and was specifically trained in all aspects of the assessments. The assessor was 
blinded to the treatment allocation by instructing the subjects in the first RCT (Skou et al., 2015b) to 
cover the study knee with three layers of white elastic tape covering a potential scar after surgery 
before meeting with the assessor. 
 
Assessment of Pain Intensity 
Peak pain intensity in the most affected knee during the previous 24 h assessed on a 100 mm VAS 
with terminal descriptors of ‘no pain’ and ‘worst pain possible’ was chosen since it has been 
frequently applied in studies on sensitisation in knee OA-related pain (Arendt-Nielsen et al., 2010; 
Skou et al., 2013a; Skou et al., 2014a). The VAS is a pain measure widely used which is valid, reliable, 
and responsive (Hawker et al., 2011). A VAS of 0-4 mm can be considered equivalent to no pain 
(Jensen et al., 2003). This limit was used to evaluate how many of the patients in each group that did 
not have knee pain at the 12-month follow-up. 
The knee pain intensity after 30 min of walking assessed on a 100 mm VAS with terminal descriptors 
of ‘no pain’ and ‘worst pain possible’ was included as an indirect measure of how knee pain affects 
function.  
 
Assessment of Sensitisation 
Bilateral PPTs were obtained using a handheld algometer with a 1 cm2 probe (Algometer Type II, 
Somedic AB, Hoerby, Sweden). The pressure was applied perpendicularly to the skin at a constant 
rate of 30 kPa/s and was increased until the subject felt a shift of the pressure into pain. At this shift 
in perception, the subject was informed to press a button, and the pressure value was stored 
defining the PPT in kPa. A previous assessment of the test procedure in a test-retest reliability and 
agreement study with 20 patients with knee OA demonstrated intra-class correlation coefficients 
and 95 % Limits of Agreement (LoA) (95% LoA; the difference between the mean difference and the 
upper and lower LoA) ranging from 0.84 to 0.91 and from 199.6 to 434.0 kPa for the different sites 
(Skou et al., 2015c). The 95% LoA corresponds to the minimal detectable change (MDC) for the 
assessment method. 
PPTs from four sites on the knee and one on the lower leg were used: 1) 3 cm medial to the 
midpoint of the medial edge of patella, 2) 2 cm proximal to the midpoint of the superior edge of 
patella, 3) 3 cm lateral to the midpoint of the lateral edge of patella, 4) at the centre of patella, and 
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2010). PPTs were obtained twice at each site, and the means of all five sites from the most affected 
and contralateral lower extremity (as defined by the subject at baseline) were calculated as 
aggregated PPT values and used in the analyses. 
 
Spreading of Pain 
The subjects shaded body sites with pain in the previous 24 hours on a region-divided body chart (26 
sites in total) at baseline and at the 12-month follow-up. The total number of pain sites was used to 




The sample size for the two respective RCTs was powered based on the primary outcome KOOS4, 
with scores ranging from 0 (worst) to 100 (best) (Roos et al., 1998; Roos and Toksvig-Larsen, 2003). 
The sample size needed to detect a 10-point difference (with a standard deviation of 14) between 
groups in KOOS4 was 41 subjects in each group (power of 90 % and a significance level of 0.05). To 
account for crossovers to TKR and for missing data, the dropout rate was set to 20%, and a total of 
100 patients were randomised in both studies. In this pre-specified ancillary analysis, we were 
interested in exploring pain and PPTs 12 months after: 1) TKR followed by non-surgical treatment, 2) 
non-surgical treatments alone, and 3) usual care. 
 
Ancillary Analyses 
The analyses of peak pain intensity, pain intensity after 30 min, PPTs from the most affected 
extremity and PPTs from the contralateral extremity were conducted using a mixed-effects model 
(including all available data points in an intention-to-treat analysis) with subject as a random effect 
and time (baseline, 12 months) and group (TKR+non-surgical, non-surgical OR non-surgical, usual 
care) as fixed effects. Interaction between time and group was also included in the model. The 
analyses were adjusted for baseline scores, gender, age, and BMI. The analyses of spreading of pain 
were conducted using Wilcoxon Signed-Rank Test (paired data) and Mann-Whitney U test (unpaired 
data) as the count data were not normally distributed. 
Furthermore, the subjects from both RCTs were combined, re-grouped, and analysed crudely and 
adjusted using the same procedure as above according to the treatment which they actually 
received. Subjects undergoing TKR during the 12-month follow-up were analysed in a TKR group 
while subjects attending at least 75% of the supervised exercise sessions (≥18 of 24 sessions) 
without undergoing TKR were analysed in a non-surgical group. The subjects in the usual care group 
and the subjects in the non-surgical groups attending less than 75% of the supervised exercise 
sessions without undergoing TKR were not included in this secondary analysis. The cut-off of 75% 
was chosen to ensure that the patients had the possibility to improve from the non-surgical 
treatment as the results from a meta-analysis suggested that more supervised exercise sessions 
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regression was applied to identify predictors of improvements in the outcomes of the group 
undergoing TKR during the 12 months and in the group attending at least 75% of the supervised 
exercise sessions without undergoing TKR, respectively. The regression analyses were adjusted for 
gender, age, and BMI. 
Finally, correlations between the outcomes and change in each individual outcome were assessed 
with Pearson’s Product-Moment Correlation for the two RCTs combined. 
As endorsed by The European Agency for the Evaluation of Medicinal Products, no adjustments for 
multiplicity were conducted as this was an ancillary analysis declared as supportive of the primary 
reports from the two RCTs (The European Agency for the Evaluation of Medicinal Products, 2002).  
The results are presented as means with 95% confidence intervals (CI). The significance level was set 
at P < 0.05, and all analyses were performed in IBM SPSS Statistics for Windows (Version 24.0, IBM 
Corporation, Armonk, NY, USA). 
 
Results 
Subject characteristics as well as  baseline and 12-months data for the outcomes are presented in 
table 1.  
RCT of TKR in addition to non-surgical treatment cohort: A total of 1475 patients seen in secondary 
care by orthopaedic surgeons were assessed for eligibility of which 1348 were ineligible, and 27 did 
not want to participate. One hundred subjects were randomised, with 46/50 (one subject did not 
undergo TKR) in the TKR + non-surgical group and 49/50 (13 subjects underwent TKR during follow-
up) in the non-surgical group completing both baseline and 12-month follow-up (Figure 1A).  
 
RCT of non-surgical treatment vs. usual care cohort: A total of 654 patients seen in secondary care by 
orthopaedic surgeons were assessed for eligibility of which 553 were ineligible, and one was not 
willing to undergo randomisation. One hundred subjects were randomised with 47/50 (three 
subjects underwent TKR during follow-up) in the non-surgical group and 44/50 (five subjects 
underwent TKR during follow-up) in the usual care group completing both baseline and 12-month 
follow-up (Figure 1B). 
 
Predictors of Pain Outcomes and Gender Differences 
In TKR subjects (N=70), aggregated PPTs at the affected limb (R2=0.110) and at the contralateral limb 
(R2=0.09) predicted a change from baseline to 12 months in pain intensity after walking (P < 0.05) 
(lower PPTs were associated with less pain improvement) while PPTs did not predict the pain 
outcome from non-surgical treatment (N=49; P > 0.05). Baseline measures of all outcomes predicted 
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Males had mean baseline PPTs of 776-857 kPa while females had 408-464 kPa. The corresponding 
PPTs were 877-947 kPa and 545-576 kPa at 12-months (P < 0.001), respectively. 
 
Although low baseline PPTs were associated with more PPT increases after treatment, the subjects 
(both cohorts) with low baseline PPTs still had the lowest 12-month PPTs for both the most affected 
side (r =0.73, P < 0.001, figure 2A) and for the contralateral side (r =0.73; P < 0.001; figure 2B). 
Furthermore, women had lower PPTs (both the most affected side and non-affected side) at baseline 
(mean difference 368-393 KPa) and at 12-months compared with men (mean difference 332-371 
KPa; P < 0.001; Figure 2A and B). A weak association (r=0.145, P =0.048) was found for baseline pain 
during 30 min walking and the same parameter after treatment. 
 
Associations between Clinical and Experimental Pain Parameters 
At baseline a weak positive association (r = 0.24; P <0.001) was found between peak pain intensity 
and number of body sites with pain. Furthermore, a weak, but negative association (r = -0.19; P = 
0.01) was found between PPT (both the most affected side and non-affected side) and number of 
body sites with pain (table 3). 
Weak positive associations were found between improvements in pain parameters from baseline to 
12 months and improvements in the number of body sites with pain (r = 0.32-0.40; P <0.001), and 
weak negative associations were found with PPTs (r = 0.17-0.23, P < 0.05). Furthermore, a weak 
negative association was found between improvements in PPT (non-affected side) and 
improvements in the number of body sites with pain (r = 0.16; P = 0.045; table 4). 
 
Intention-to-treat Analysis 
RCT of TKR in addition to non-surgical treatment: In the intention-to-treat analysis, the group 
randomised to TKR followed by non-surgical treatment had a 15 mm significantly (P < 0.05) greater 
improvement in peak pain intensity during the last 24h than the group randomised to non-surgical 
treatment alone. The differences between groups were not significant for pain intensity after 30 min 
walking and PPTs (table 5). In the adjusted within-group analyses, both groups improved significantly 
in peak pain intensity, pain intensity after 30 min walking, and both PPT measures (table 5). Twenty-
five of the patients randomised to TKR followed by non-surgical treatment and 15 of the patients 
randomised to non-surgical treatment alone had not had knee pain during the last 24h at the 12-
month follow-up. The group randomised to TKR followed by non-surgical treatment had a 
significantly larger reduction in the number of body sites with pain at the 12-month follow-up 
compared with the group randomised to non-surgical treatment alone (Z = -2.116; p = 0.034; Table 
1). 
Both the group randomised to TKR followed by non-surgical treatment (Z = -4.195; p < 0.001; Table 
1) and the group randomised to non-surgical treatment alone (Z = -2.349; p = 0.019; Table 1) had 
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RCT of non-surgical treatment vs. usual care: In the intention-to-treat analysis, the group 
randomised to non-surgical treatment had a significantly greater improvement in peak pain intensity 
of 16 mm and pain intensity after 30 min walking of 27 mm than the group randomised to usual care 
(P < 0.05). The differences between groups were not significant for PPTs (table 5). In the adjusted 
within-group analyses, both groups improved significantly in peak pain intensity and both PPT 
measures while only the group randomised to non-surgical treatment improved significantly in pain 
intensity after 30 min walking (table 5). Fourteen of the patients randomised to non-surgical 
treatment and 7 of the patients randomised to usual care had not had knee pain during the last 24h 
at the 12-month follow-up. The group randomised to non-surgical treatment did not have a larger 
reduction in the number of body sites with pain at the 12-month follow-up compared with the group 
randomised to usual care (Z = -1.046; p = 0.296; Table 1). 
Neither the group randomised to non-surgical treatment (Z = -1.773; p = 0.076; Table 1) nor the 
group randomised to usual care (Z = -0.511; p = 0.609; Table 1) had fewer body sites with pain at the 
12-month follow-up compared with baseline. 
 
Secondary Analysis 
Combined analysis of subjects undergoing TKR vs. subjects undergoing non-surgical treatment: 
In the secondary analysis, the 70 subjects from the two RCTs undergoing TKR during follow-up were 
compared with the 49 subjects attending at least 75% of the supervised exercise sessions without 
undergoing TKR during follow-up. The group undergoing TKR had a 14 and 13 mm significantly (P < 
0.05) greater improvement in pain intensity after 30 min walking (in the crude and the adjusted 
analysis) than the group undergoing non-surgical treatment. The differences between groups were 
not significant for peak pain intensity and PPTs (table 6). In the adjusted within-group analyses, both 
groups improved significantly in peak pain intensity, pain intensity after 30 min walking, and PPTs 
(table 6). The group undergoing TKR had a significantly larger reduction in the number of body sites 
with pain at the 12-month follow-up compared with the group undergoing non-surgical treatment (Z 
= -2.377; p = 0.017). The group undergoing TKR had significantly fewer body sites with pain at the 
12-month follow-up compared with baseline (Z = -4.471; p < 0.001) while the group undergoing non-
surgical treatment had not (Z = -1.305; p = 0.192). 
 
Discussion  
The present data showed that: 1) low aggregated PPTs (from both affected and non-affected lower 
limbs) at baseline predicted higher clinical pain after TKR, 2) the number of painful body sites 
predicted higher clinical pain after TKR and lower aggregated PPT values, 3) subjects with the highest 
pain and lowest aggregated PPTs at baseline showed the largest relative improvement in both pain 
and PPTs, but were still experiencing the highest absolute pain levels and lowest aggregated PPTs 
after 12 months (combined cohorts), and 4) baseline pain intensity and PPT levels were associated 
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Females had the lowest PPTs both at baseline and after 12 months. 
This OA study is the first to include: A) an aggregated PPT measure from different locations in the 
prediction of the outcome after TKR, and: B) to investigate if the effect on non-surgical interventions 
could be predicted.  
 
Predicting Outcome of Intervention 
In recent years, possible clinical and experimental parameters predicting outcome after TKR 
(Mannion et al., 2009; Gandhi et al., 2010; Sullivan et al., 2011; Merle-Vincent et al., 2011; Petersen 
et al., 2015b) have been a focus, but no studies have investigated possible associations between 
preoperative pain sensitisation parameters and outcome after non-surgical interventions for 
managing OA pain. Approximately one quarter of all patients undergoing joint (hip and knee) 
replacements are suggested to be considered inappropriate candidates for joint surgery  (Quintana 
et al., 2009; Cobos et al., 2010). Specific sub-groups of OA pain patients with different degrees of 
sensitisation have been identified  (Finan et al., 2013; King et al., 2013; Skou et al., 2014a; Arendt-
Nielsen et al., 2015a),and such specific sub-groups may respond differently to the interventions.  
In recent years, different pain sensitisation measures have been developed and applied in addition 
to PPTs. In the current comprehensive RCTs, it was only possible for practical reasons to assess PPTs 
although other measures have shown promising results. Preoperative temporal summation has, for 
example, been consistently shown to predict continued pain following TKR surgery in patients with 
OA (Petersen et al., 2015a; Petersen et al., 2016).  
More consistent mechanisms related to centralised sensitisation such as facilitated temporal 
summation seem to be a characteristic of those patients experiencing less pain relief after TKR  
(Petersen et al., 2016) and seem related to the present findings where low PPTs predicted less 
beneficial effect of TKA surgery. This has important clinical implications as the risk of re-revision is 
four to five times higher than the risk of revision of the original primary procedure (Australian 
Orthopaedic National Joint Replacement Registry, 2010) and since patients with pain afte one or 
more revision TKRs are severely affected by pain and sensitisation (Skou et al., 2013b). The study 
also showed a consistent influence of the preoperative pain level for the 12-month pain outcome 
after TKR and hence supports previous studies (Hovik et al., 2016).  
In both the surgical and non-surgical group, the pain and PPT levels individually predicted their own 
outcomes.  
 
Associations Between Clinical and Experimental Pain Parameters 
When an experimental pain stimulus (e.g. for assessing PPT) is applied to an extraterritorial (outside 
the nerve innervation area with the painful condition such as OA), contralateral or extrasegmental 
site, it can provide information about the spreading of pain hypersensitivity outside the affected 
area (Arendt-Nielsen et al., 2017). Furthermore, the spreading of pain and pain hypersensitivity tend 
to follow this pattern involving an increasing part of the central nervous system and end up 
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Therefore, experimental pain assessment by PPT outside a painful area may be interpreted as 
spreading sensitisation, and in OA patients the degree of sensitisation depends on the clinical pain 
intensity and pain duration (Arendt-Nielsen et al., 2015a). This further supports the concept that the 
ongoing nociceptive activity is the driver for increased central gain (Voscopoulos and Lema, 2010; 
Shipton, 2011). In parallel, the descending pain pathways may start to enhance the excitability along 
the entire neuroaxis due to a shift in balance between pain inhibitory and pain facilitatory pathways 
(Millan, 2002; Vanegas and Schaible, 2004). In addition, the present study showed that the clinical 
pain intensity, the number of painful sites assessed clinically, and the PPTs were all associated. 
Successfully relieving joint pain in OA patients by surgery normalises PPTs (resets the centralised 
sensitisation processes) (Graven-Nielsen et al., 2012; Aranda-Villalobos et al., 2013), supporting the 
notion that ongoing pain may be the driving factor for development of sensitisation  (Noiseux et al., 
2014). Further, this is supported by animal model studies (Scholz et al., 2005).   
In the present study, each of the three interventions significantly increased the PPTs from 
both the affected and non-affected sides. 
 
The Effect of the Interventions on Pain and PPTs 
The compiled data from the two RCTs confirmed TKR in addition to non-surgical treatment as the 
most efficient treatment followed by the non-surgical procedure alone and with usual care as the 
least efficient (Skou et al., 2015a; Skou et al., 2015b).  
The most commonly used technique to assess pain sensitisation in OA patients is externally applied 
pressure and assessment of the associated PPT (Suokas et al., 2012; Fingleton et al., 2015). 
Approximately, 70% of knee OA patients have at least one somatosensory abnormality (Wylde et al., 
2012). 
However, it is not obvious which structures the pressure is activating, but it may predominantly be 
extra-articular structures as patients with pain after TKR still have lowered PPTs when assessed over 
the replaced joint structures (Skou et al., 2014a).  
Pain sensitisation is confirmed to play an important role in the clinical presentation of knee OA pain 
(Kidd, 2012). Therefore, attempts have been made to develop clinical (Akinci et al., 2016) and 
experimental quantitative measures (Arendt-Nielsen et al., 2015b) for assessing sensitisation in OA. 
The present study collected PPTs from the most affected leg (interpreted as segmental sensitisation) 
as well as the contralateral leg (interpreted as wide-spread sensitisation).  
The lowest PPTs at baseline were found in females which supports the data by Bartley et al. (Bartley 
et al., 2016). We extended those findings and showed that this lower level lasted 12 months after 
treatment. 
As a novel finding from this study, the number of painful body sites was associated with the lower 
PPTs from the non-affected side. This corresponds to the previously proposed concept that 
spreading of pain and spreading of sensitisation gradually develop over time as the pain persists 
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 Associations between the number of painful body sites, pain intensity, and catastrophising have 
previously been shown (Dave et al., 2015; Skou et al., 2016b; Skou et al., 2016c). Previously, body 
maps of pain have shown extensive increases in the pain areas when the patients experience 
continued pain after TKR (Skou et al., 2013b).  
 
Limitations 
The paradigms used for the non-surgical procedure were based on current evidence. However, it is 
not known whether it could be further improved to address other problems related to OA such as 
sensitisation. Furthermore, since all patients were included from an orthopaedic outpatient clinic in 
secondary care, and due to the specific eligibility criteria, it is unknown whether the results can be 
generalised to all patients with knee OA. The quantitative sensory testing (QST) modality used in the 
present studies was limited to PPTs. As the study had to fit into the clinical routines, it was 
unfortunately not possible to include more QSTs although it would have been very interesting as, 
e.g. temporal summation is a strong predictor of the outcome after hip replacement (Petersen et al., 
2015a; Petersen et al., 2016; Izumi et al., 2017). Static PPT assessments with a handheld algometer 
have the limitation that they assess only the sensitivity at the very local site. Previously, the PPT has 
been shown to vary along a muscle (Andersen et al., 2006) and at an OA affected knee joint (Arendt-
Nielsen et al., 2015a).    
Many factors including psychological factors (e.g. catastrophising) are important in OA (Egsgaard et 
al., 2015) and are also predictors of continued post-operative pain in most studies (Lewis et al., 
2015),but not in all (Hovik et al., 2016).  
The RCT2 (non-surgical treatment compared with usual care) included patients with K&L of 1-4 while 
the RCT1 (Non-surgical treatment +/- TKR) included patients with K&L of 2-4, indicating that there 
might be differences in the radiographic severity which could potentially affect the comparability of 
the non-surgical groups of the two RCTs. However, the improvements from the non-surgical 
treatment were comparable in the two RCTs (Skou et al., 2015a; Skou et al., 2015b), and a previous 
meta-analysis has highlighted that radiographic severity at baseline is not associated with the 
outcome from non-surgical treatment (Juhl et al., 2014). 
As a new composit measure of pressure pain hypersensitivity, the aggregated PPT values from all the 
points on the affected and un-affected limb were also used. It would have been possible to analyse 
all the individual PPT values, but this was not the major aim and purpose of the present study. 
 
Conclusion 
The main findings based on the secondary analysis of two RCT cohorts were: 1) low PPTs 
(from affected and non-affected sites) at baseline were weakly associated with worse clinical 
outcome after TKR, but did not predict the outcome after non-surgical interventions, 2) the 
number of painful body sites was weakly associated with pain and PPTs, and 3) and the 
higher pain/lower PPTs, the higher pain/lower PPTs after 12 months with females showing 
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improved pain more than the non-surgical program alone, and the non-surgical program 
improved pain more than usual care. 
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Study flow of the randomized, controlled trials of patients eligible for total knee replacement (TKR; 
Figure A) and not eligible for TKR (Figure B) from which data in the present study are derived. 
 
Figure 2. 
The association between baseline pressure pain thresholds (PPTs) and PPTs assessed after 12 
months (available data from the 200 subjects from the two randomised, controlled trials were 
included). Lower PPTs were associated with lower 12-month PPTs assessed at the most affected side 
(r =0.73, P < 0.001, panel A) and from the contralateral side (r =0.73, P < 0.001, panel B). Red 
diamonds represent females and blue represent males. Females had lower PPTs from the affected 
and non-affected side at baseline (mean difference 368-393 KPa) and at 12-months when compared 
with males (mean difference 332-371 KPa; P < 0.001). Males had mean baseline PPTs of 776-857 kPa 
while females had 408-464 kPa. The corresponding PPTs at 12-months were 877-947 kPa and 545-
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Table 1. Subject characteristics, baseline and 12-months data for the outcomes. RCT: 
Randomized, controlled trial; TKR: Total knee replacement; PPT: Pressure pain threshold 
(kPa) assessed with a handheld pressure algometer at the knee and lower leg. N= number of 
subjects.  
 RCT of TKR + non-surgical  RCT of non-surgical vs. 
usual care 









Women, N (%) 32 (64) 30 (60) 26 (52) 25 (50) 
Age (years), mean (SD) 65.8 (8.7) 67.0 (8.7) 64.8 (8.7) 67.1 (9.1) 
Body mass index, mean 
(SD) 
32.3 (6.2) 32.0 (5.8) 30.6 (5.6) 29.4 (5.2) 
Bilateral knee pain, N (%) 18 (36) 17 (34) 18 (36) 21 (42) 
Duration of knee 
symptoms, N (%) 
    
     0–6 months 0 (0) 6 (12) 4 (8) 2 (4) 
     6–12 months 5 (10) 2 (4) 9 (18) 6 (12) 
     1–2 years 8 (16) 8 (16) 10 (20) 5 (10) 
     2–5 years 15 (30) 10 (20) 11 (22) 13 (26) 
     5–10 years 11 (22) 12 (24) 4 (8) 8 (16) 
    More than 10 years 11 (22) 12 (24) 12 (24) 16 (32) 
Radiographic knee OA 
severity (Kellgren-
Lawrence), N (%) 
    
    Grade 1 ---- ---- 7 (14) 11 (22) 
    Grade 2 7 (14) 5 (10) 13 (26) 15 (30) 
    Grade 3 21 (42) 21 (42) 13 (26) 10 (20) 
    Grade 4 22 (44) 24 (48) 17 (34) 14 (28) 
Peak pain intensity in the 
previous 24h,  
(0–100), mean (SD) 
    
    Baseline 52 (26) 55 (22) 60 (23) 56 (25) 
    12 months 19 (26) 35 (31) 26 (23) 39 (30) 
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walking, (0–100), mean 
(SD) 
    Baseline 63 (29) 67 (25) 62 (26) 47 (24) 
    12 months 19 (26) 38 (32) 28 (26) 42 (28) 
PPTs at affected extremity, 
mean (SD) (kPa) 
    
    Baseline 554 (318) 573 (322) 549 (257) 592 (314) 
    12 months 720 (336) 669 (295) 699 (289) 661 (310) 
PPTs at contralateral 
extremity, mean (SD) 
(kPa) 
    
    Baseline 661 (365) 610 (332) 606 (264) 660 (336) 
    12 months 750 (346) 734 (307) 726 (308) 728 (338) 
Number of body sites with 
pain in the previous 24h, 
mean (SD) 
    
    Baseline 3.1 (2.2) 3.3 (2.6) 3.2 (2.9) 2.8 (2.1) 
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Table 2. Predictors of improvements in outcome from baseline to 12 months in subjects 
undergoing TKR and subjects undergoing non-surgical treatment only. A total of 70 subjects 
from the two randomized controlled trials undergoing total knee replacement (TKR) during 
follow-up and 49 subjects attending at least 75% of the supervised exercise sessions without 
undergoing TKR during follow-up (non-surgical treatment) were included in the analyses; the 
results were adjusted for age, gender, and body mass index. P-values indicate the P-values 
for the specific predictor in the model. PPT=Pressure Pain Threshold (kPa). 
Condition R2 P-value Unstandardized Beta 
(95% CI) 
Total knee replacement group    
Peak pain intensity as a predictor of 
improvement in peak pain intensity 
0.448 < 0.001 0.907 (0.618 to 1.196) 
Pain intensity after walking as a 
predictor of improvement in pain after 
walking 
0.496 < 0.001 0.881 (0.645 to 1.117) 
PPTs at affected extremity as a predictor 
of improvement in peak pain intensity 
0.096 0.30 0.018 (-0.016 to 0.053) 
PPTs at affected extremity as a predictor 
of improvement in pain after walking 
0.110 0.02 0.041 (0.007 to 0.075) 
PPTs at contralateral extremity as a 
predictor of improvement in peak pain 
intensity 
0.082 0.69 0.006 (- 0.025 to 0.037) 
PPTs at contralateral extremity as a 
predictor of improvement in pain after 
walking 
0.090 0.04 0.032 (0.002 to 0.062) 
PPTs at affected extremity as a predictor 
of improvement in PPTs at affected 
extremity 
0.141 0.02 - 0.358 (- 0.654 to - 
0.061) 
PPTs at contralateral extremity as a 
predictor of improvement in 
contralateral PPTs 
0.161 0.01 - 0.361 (- 0.618 to - 
0.103) 
Non-surgical treatment group    
Peak pain intensity as a predictor of 
improvement in peak pain intensity 
0.295 < 0.001 0.853 (0.432 to 1.274) 
Pain intensity after walking as a 
predictor of improvement in pain after 
walking 
0.256 0.01 0.671 (0.281 to 1.061) 
PPTs at affected extremity as a predictor 
of improvement in peak pain intensity 
0.047 0.34 0.022 (- 0.025 to 0.069) 
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of improvement in pain after walking 
PPTs at contralateral extremity as a 
predictor of improvement in peak pain 
intensity 
0.032 0.64 0.012 (- 0.039 to 0.063) 
PPTs at contralateral extremity as a 
predictor of improvement in pain after 
walking 
0.084 0.23 0.030 (- 0.019 to 0.079) 
PPTs at affected extremity as a predictor 
of improvement in PPTs at affected 
extremity 
0.287 < 0.001 - 0.375 (- 0.585 to -
0.165) 
PPTs at contralateral extremity as a 
predictor of improvement in 
contralateral PPTs 




Table 3. Associations between baseline parameters for available data from all subjects from 















Peak pain intensity 
in the previous 24h 
r =0.41 
P < 0.001 
r =-0.10 
P = 0.19 
r =-0.13 
P = 0.07 
r =0.24 
P < 0.001 
Pain intensity after 
30 min walking  ------- 
r =0.03 
P = 0.72 
r =0.02 
P = 0.84 
r =0.07 
P = 0.34 





P < 0.001 
r =-0.19 
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Table 4. Associations between the improvements in outcome parameters from baseline to 12 
months for available data from all subjects from the two RCT cohorts combined (N=200). 















Peak pain intensity 
in the previous 24h 
r = 0.60 
P < 0.001 
r = 0.20 
P = 0.01 
r = 0.20 
P = 0.01 
r = 0.40 
P < 0.001 
Pain intensity after 
30 min walking  ------- 
r = 0.23 
P = 0.01 
r = 0.17 
P = 0.04 
r = 0.32 
P < 0.001 




r = 0.71 
P < 0.001 
r = 0.14 






r = 0.16 
P = 0.045 
 
 
Table 5. Group differences in the adjusted intention-to-treat analysis. In the adjusted analyses 
the results were adjusted for baseline scores, gender, age, and BMI. For the ‘Mean 
improvement’ column a positive number indicates an improvement for that parameter. For 
the ‘Difference in mean improvement’ column a positive number indicates a larger 
improvement in the intervention group (TKR/non-surgical) for that parameter. #: P< 0.05, ##: 
P<0.001. PPT=Pressure Pain Threshold (kPa). 
 
 Mean improvements in RCT 
of TKR + non-surgical vs. 
non-surgical 
(95% CI) 





Mean improvement in 
RCT of non-surgical 
vs. usual care 
(95% CI) 















intensity in the 
previous 24h 
34.6## 
(23.5 to 45.7) 
19.6## 
(9.7 to 29.5) 
15.1# 








(1.8 to 29.9) 
Pain intensity 
after 30 min 
walking  
42.9##  


































































Table 6. Group differences in the secondary analysis. In the secondary analysis, the 70 
subjects from the two randomized controlled trials undergoing total knee replacement (TKR) 
during follow-up were compared with the 49 subjects attending at least 75% of the supervised 
exercise sessions without undergoing TKR during follow-up. In the adjusted analyses the 
results were adjusted for baseline scores, gender, age, and BMI.  
For the ‘Mean adjusted within group improvement” column a positive number indicates an 
improvement for that parameter. For the ‘Difference in mean improvement” column a 
positive number indicates a larger improvement in the intervention group (TKR/non-surgical) 




Mean adjusted within group 
improvement  
(95% CI)  
Difference in mean improvement  
TKR – non-surgical  
(95% CI) 
TKR Non-surgical  Crude Adjusted 
Peak pain intensity 
in the previous 24h 
33.2## 
(24.6 to 41.9) 
21.6## 
(11.4 to 31.8) 
10.8 
(-2.2 to 23.8) 
11.6 
(-1.6 to 24.8) 
Pain intensity after 
30 min walking  
42.9## 
(34.4 to 51.3) 
29.6## 
(19.5 to 39.6) 
14.1# 
(1.3 to 26.9) 
13.3# 
(0.3 to 26.3) 
PPTs at affected 
extremity 
174.2## 
(101.1 to 247.2) 
124.8## 
(71.2 to 178.3) 
53.1 
(-40.5 to 146.7) 
51.4 
(-42.3 to 145.1) 
PPTs at contralateral 
extremity 
143.9## 
(72.4 to 215.3) 
110.0## 
(51.1 to 168.8) 
36.0 
(-58.5 to 130.5) 
36.2 


































Attended 12-month follow-up (n=49) 
    Did not attend (n=1) 
        No longer interested (n=1)       
         
Assessed for eligibility in trial of patients eligible for TKR (n=1475) 
Not eligible (n= 1348) 
Found not eligible for TKR (n=544) 
    OA not severe enough, K-L score < 2 (n=197) 
    Needed bilateral knee replacement (n=50) 
    Previous same side knee replacement (n=49) 
    Rheumatoid Arthritis (n=30) 
    VAS > 60mm out of 100 mm (n=117) 
    Unable to come to the treatment site (n=145) 
    Not able to participate in the intervention (n=180) 
    Other reasons (n=36) 
Included in the intention-to-treat analysis (n=50) 
Attended 12-month follow-up (n=46) 
    Did not attend (n=4) 
        No longer interested (n=3)       
        Had complications related to TKR (n=1) 
Allocated to TKR+non-surgical treatment (n=50) 
    Did not undergo TKR during follow-up (n=1) 
    Underwent TKR (n=49) 
Allocated to non-surgical treatment (n=50) 
    Underwent TKR during follow-up (n=13)  
    Did not undergo TKR during follow-up (n=37) 






Eligible for inclusion (n=127) 
Did not want to undergo TKR (n=12) 
Did not want to undergo non-surgical treatment (n=7) 














Attended 12-month follow-up (n=44) 
    Did not attend (n=6) 
        No longer interested (n=2)       
        Cancelled and not possible to reach (n=1) 
        Personal or health issues (n=1) 
        Unhappy with group allocation (n=1) 
       Had died (n=1)     
Excluded (n= 553) 
    Eligible for TKR (n=192) 
    K-L score < 1 (n=87) 
    Aged < 18 years (n=26) 
    KOOS4 > 75 (n=22) 
    Previous same side knee replacement (n=44) 
    Rheumatoid Arthritis (n=11) 
    VAS > 60mm out of 100 mm (n=12) 
   Unable to comply with study protocol (n=159)
Included in the intention-to-treat analysis (n=50) 
Attended 12-month follow-up (n=47) 
    Did not attend (n=3) 
        No longer interested (n=1)       
        Cancelled and not possible to reach (n=1) 
        Had died (n=1)     
   
Allocated to non-surgical treatment (n=50) 
    Received the allocated treatment (n=48)  
    Did not want the treatment anyway (n=2) 
    Underwent TKR during follow-up (n=3) 
Allocated to written advice (n=50) 
    Received the allocated treatment (n=50) 
    Underwent TKR during follow-up (n=5) 






Eligible for inclusion (n=101) 
Unwilling to be randomised (n=1) 
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